发明名称 METHODS FOR MODULATING C9ORF72 EXPRESSION
摘要 Disclosed herein are methods for reducing expression of C90RF72 mRNA and protein in an animal with C90RF72 specific inhibitors. Such methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof. Such C90RF72 specific inhibitors include antisense compounds. Examples of neurodegenerative diseases that can be treated, prevented, and ameliorated with the administration C90RF72 specific inhibitors include amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), corticalbasal degeneration syndrome (CBD), atypical Parkinsonian syndrome, and olivopontocerellar degeneration (OPCD).
申请公布号 EP2906696(A4) 申请公布日期 2016.06.08
申请号 EP20130846313 申请日期 2013.10.15
申请人 IONIS PHARMACEUTICALS, INC.;LUDWIG INSTITUTE FOR CANCER RESEARCH LIMITED;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 发明人 RIGO, FRANK;CLEVELAND, DON W.;LAGIER-TOURENNE, CLOTILDE;RAVITS, JOHN M.;BENNETT, C. FRANK;FREIER, SUSAN M.;BAUGHN, MICHAEL W.
分类号 C12N15/113;A61P25/28 主分类号 C12N15/113
代理机构 代理人
主权项
地址
您可能感兴趣的专利